English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Tonix Pharmaceuticals (TNXP.US)$ CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a biopharmaceutical company, has announced its intention to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Tonmya™, a non-opioid analgesic aimed at treating fibromyalgia. The company plans to apply to the second half of 2024 following promising results from two Phase 3 trials.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
2
Translate
Report
5187 Views
Comment
Sign in to post a comment
4916
Followers
24
Following
70K
Visitors
Follow
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.